Compare AXGN & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AXGN | BCRX |
|---|---|---|
| Founded | N/A | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.6B |
| IPO Year | N/A | 1994 |
| Metric | AXGN | BCRX |
|---|---|---|
| Price | $33.29 | $6.76 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 11 |
| Target Price | ★ $33.67 | $20.82 |
| AVG Volume (30 Days) | 1.0M | ★ 4.3M |
| Earning Date | 02-24-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $214,709,000.00 | ★ $599,816,000.00 |
| Revenue This Year | $21.98 | $40.21 |
| Revenue Next Year | $15.61 | $6.13 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 18.72 | ★ 45.38 |
| 52 Week Low | $9.22 | $6.00 |
| 52 Week High | $36.00 | $11.31 |
| Indicator | AXGN | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 49.68 | 51.18 |
| Support Level | $30.98 | $6.26 |
| Resistance Level | $35.65 | $6.91 |
| Average True Range (ATR) | 1.70 | 0.26 |
| MACD | -0.27 | 0.06 |
| Stochastic Oscillator | 43.43 | 85.92 |
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.